# Ascentage Pharma Group International: Form 20-F for the period ended Dec 31, 2025

- Company: [Ascentage Pharma Group International](/companies/aapg.md) (CIK 2023311)
- Form: 20-F
- Filed: 2026-04-29
- Accepted by EDGAR: Apr 29, 2026, 17:19 ET
- Period: 2025-12-31
- Accession: 0001213900-26-049412
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/2023311/000121390026049412/ea0285148-20f_ascentage.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/2023311/000121390026049412/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/2023311/000121390026049412/ea0285148-20f_ascentage.htm

Filed Apr 29, 2026.
Source: SEC EDGAR, the filing index for accession 0001213900-26-049412. Last ingested by Listed: Nov 5, 2026, 12:38 ET. No prices; not investment advice.